New‐onset atypical fulminant type 1 diabetes after COVID‐19 vaccination: A case report

Takaaki Kobayashi; Fumiyoshi Yakou; Masuo Saburi; Ai Hirose; Hiroaki Akaoka; Yusuke Hirota; Daisuke Yunaiyama; Nobuteru Asahi; Atsushi Ohno; Takaya Matsushita

doi:10.1002/ccr3.6473

Clinical Case Reports (Oct 2022)

New‐onset atypical fulminant type 1 diabetes after COVID‐19 vaccination: A case report

Takaaki Kobayashi,
Fumiyoshi Yakou,
Masuo Saburi,
Ai Hirose,
Hiroaki Akaoka,
Yusuke Hirota,
Daisuke Yunaiyama,
Nobuteru Asahi,
Atsushi Ohno,
Takaya Matsushita

Affiliations

Takaaki Kobayashi: Department of Diabetology Endocrinology and Metabolism Tokyo Medical University Hachioji Medical Center Hachioji Japan
Fumiyoshi Yakou: Department of Diabetology Endocrinology and Metabolism Tokyo Medical University Hachioji Medical Center Hachioji Japan
Masuo Saburi: Department of Diabetology Endocrinology and Metabolism Tokyo Medical University Hachioji Medical Center Hachioji Japan
Ai Hirose: Department of Diabetology Endocrinology and Metabolism Tokyo Medical University Hachioji Medical Center Hachioji Japan
Hiroaki Akaoka: Department of Diabetology Endocrinology and Metabolism Tokyo Medical University Hachioji Medical Center Hachioji Japan
Yusuke Hirota: Department of Diabetology Endocrinology and Metabolism Tokyo Medical University Hachioji Medical Center Hachioji Japan
Daisuke Yunaiyama: Department of Radiology Tokyo Medical University Shinjuku‐ku Japan
Nobuteru Asahi: Department of Diabetology Endocrinology and Metabolism Tokyo Medical University Hachioji Medical Center Hachioji Japan
Atsushi Ohno: Department of Diabetology Endocrinology and Metabolism Tokyo Medical University Hachioji Medical Center Hachioji Japan
Takaya Matsushita: Department of Diabetology Endocrinology and Metabolism Tokyo Medical University Hachioji Medical Center Hachioji Japan

DOI: https://doi.org/10.1002/ccr3.6473
Journal volume & issue: Vol. 10, no. 10
pp. n/a – n/a

Abstract

Read online

Abstract Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID‐19) vaccination have been reported. Herein, we report a case of a man who developed anti‐glutamic acid decarboxylase (GAD) antibody‐positive fulminant type 1 diabetes 15 weeks after COVID‐19 vaccination, atypical of the previously reported anti‐GAD antibody‐negative cases.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords